Tissue Diagnostics Market Size, Leading Players, Segments Analysis and Forecast Report 2024

A recent trend observed in the tissue diagnostics industry is increasing usage of immunohistochemistry products as companion diagnostics devices. Increasing prevalence of cancer has fuelled the demand of better diagnostic techniques, which could detect cancer in the earliest stage. According to the WHO, in 2012, there were 14 million new cancer cases and 8.2 million cancer related deaths worldwide.

The global tissue diagnostics market is categorized on the basis of product type, technology, application, and end-user. Based on product type, the tissue diagnostics market can be categorized as instruments and consumables. On the basis of technology, the tissue diagnostics market is categorized as digital pathology and workflow management, in situ hybridization, immunohistochemistry, and special staining. The immunohistochemistry segment leads the global tissue diagnostics market in terms of market size.

To Learn More About this report at: http://bit.ly/2Q76du2

Geographically, North America will be leading the global tissue diagnostics market in the coming years due to high prevalence of cancer cases, high healthcare expenditure, and presence of a large number of hospitals and pharmaceutical companies. Additionally, the legislative reform of Affordable Care Act in the U.S. is also expected to drive the North American market in the coming years.

Asia-Pacific is the fastest growing region in the global tissue diagnostics market. The major reasons for the fastest growth in the region are aging population, increasing disposable income, and improving healthcare infrastructure. Moreover, the tissue diagnostics marketis growing due to large unexplored tissue diagnostics market and large population base suffering with cancer in the emerging economies, such as India and China, of Asia-Pacific region.

Some of the major players operating in the global tissue diagnostics market are F. Hoffmann-La Roche AG., Sigma Aldrich Corporation, Abbott, Biogenex Laboratories, BioSB, Cell Signalling Technology Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, GE Healthcare, and Siemens Healthcare.

Read More

Weight Management Market Size, Share, Segment Analysis and Forecast Report 2024

The global weight management market size is growing significantly due to escalating technological advancement, increasing innovation in weight management ingredients, and increasing prevalence of obesity. According to National Health and Nutrition Examination Survey (NHANES) in 2009-10, more than 78 million U.S. adults were obese. Similarly, as per World Health Organization (WHO), approximately 2.8 million people die each year due to obesity.

The weight management market is categorized on the basis of diet and equipment. On the basis of diet, the market can be categorized as meals, supplements, and beverages. Diet leads the market due to increasing prevalence of obese cases, technological advancement and increasing health consciousness of people. The meals can be further segmented as meal replacement, organic food and others; whereas, supplements can be segmented as protein, fiber and others.

To Learn More About this report at: http://bit.ly/38Z2l7h

On the basis of equipment, the market can be categorized as fitness equipment, and surgical equipment. The fitness equipment includes cardiovascular training equipment and strength training equipment. The cardiovascular training equipment leads the market under fitness equipment category. The surgical equipment further includes minimally invasive surgical equipment and non-invasive surgical equipment. Minimally invasive surgical equipment includes gastric bypass surgery, laparoscopic adjustable gastric banding system, laparoscopic sleeve gastrectomy, and others. Non-invasive surgical equipment includes intragastric balloon systems, endoscopic stapling, endobarrier and others.

Asia-Pacific is the fastest growing region in the global weight management market. The major reasons for the fastest growth of weight management market in the region are increasing medical tourism, large pool of patients, and increasing healthcare expenditure. Moreover, the weight management market is growing due to increasing awareness of weight management, and refining healthcare infrastructure in the emerging countries, such as India and China, of Asia-Pacific region.

Global Weight Management Market Key Players:

• Amer Sports
• Technogym SPA
• Weight Watchers International Inc.
• Ediets.Com Inc.
• Jenny Craig Inc.
• Medtronic Inc.
• Kellogg Company
• Brunswick Corporation
• Jenny Craig Inc.
• Atkins Nutritionals Inc.
• Herbalife Ltd.
• Apollo Endosurgery Inc.
• Nutrisystem Inc.
• Cyber International, Inc.
• Johnson & Johnson.

Read More

Next-Generation Sequencing Market Size Will Make a Huge Impact in Near Future

The global next-generation sequencing market is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years.

The advanced research and development activities by the major players are propelling the demand for cost effective and efficient next-generation sequencing platforms. However, interpretation of large volume of complex sequencing data through next-generation sequencing platforms is a major challenge in global next-generation sequencing market.

The global next-generation sequencing market is categorized as technology type, sequencing workflow, applications, and end-users. Based on technology type, the next-generation sequencing market is categorized as pyrosequencing, ion-semiconductor sequencing, sequencing by synthesis, single molecule realtime sequencing, and sequencing by ligation. The sequencing by synthesis segment leads the global next-generation sequencing market. Based on sequencing workflow, the next-generation sequencing market is categorized as next-generation pre-sequencing, next-generation sequencing platforms, and next-generation sequencing services.

Inquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=next-generation-sequencing-market

Based on applications, the next-generation sequencing market can be categorized as diagnostics, drug discovery, animal and agriculture research, personalized medicine, and others. End-users of next-generation sequencing include academic and research institutes, biopharmaceutical and biotechnology companies, hospitals, and others. Academic and research institutes lead the global next-generation sequencing market.

Some of the major players operating in the global next-generation sequencing market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Biomatters, Ltd., GATC Biotech AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd, Macrogen, Inc. among others.

Read More

Latin America Wound Dressing Market Size, Regional Analysis, Key Players and Future Scope

A recent P&S Intelligence study has estimated the 2024 value of the Latin America wound dressing market to be $400.9 million. The key drivers of the domain’s growth are rising prevalence of diabetes, growing geriatric population and number of patients with chronic wounds, and high brain injury rate.

When segmented by type, the domain can be categorized into traditional dressings and advanced dressings. In 2018, the advanced dressings category is estimated to account for more than 60.0% share in the LATAM wound dressing market due to the rising utilization of such products in complex application areas as well as the growing number of people with chronic diseases. Advanced dressings further consist of the hydrocolloids, foams, alginates, films, collagen, hydrogels, wound contact layers, superabsorbent, hydrofiber, and others subcategories. Among all these, foam dressings are the most preferred type of advanced dressing in the Latin American region.

Both, acute and chronic wounds, can be managed with wound dressing. Now, chronic wounds consume more dressing material compared to the acute type due to their more severe nature. It is being estimated that the wound dressing demand for chronic wounds will contribute a $200 million revenue to the Latin America (LATAM) wound dressing market in 2018. Coming to the acute wounds category, it is further subdivided into burns, and surgical and traumatic wounds. Of these, the surgical and traumatic wounds subdivision is expected to generate the larger revenue in 2018 (91.0% share).

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=latam-wound-dressing-market

The domain is expected to grow the most in Brazil during the forecast period, primarily due to government research and development programs and increasing chronic injury incidents in the country. For instance, Brazilian Synchrotron Light Laboratory carried out a research, according to which nitric oxide (NO) may prove effective as a dressing material ingredient for chronic wounds. The research seeks to develop a product based on the use of supramolecular poly (acrylic acid) hydrogel, which contains an NO donor in the form of S-nitrosoglutathione along with the nanometric micelles of another polymer.

LATAM wound dressing market players, such as DeRoyal Industries Inc., Hollister Incorporated, Smith & Nephew plc, Johnson & Johnson, 3M Company, Mölnlycke Health Care AB, BSN Medical GmbH, Acelity L.P. Inc., Coloplast A/S., B. Braun Melsungen AG, and HARTMANN GROUP., are benefiting from product approvals in the region.

Read More

DNA Sequencing Market Trends, Business Strategies and Opportunities with Key Players Analysis 2024

The global DNA Sequencing market size is projected to achieve a lucrative growth based on the advent of technological innovations and extensive clinical applications. The market is expected to be led by consumable products, in terms of both size and growth during the forecast period (2018-2023). This is attributed to the extensive use of consumables for sample preparation, cluster generation, and other processes during the course of experiments.

The key trends observed in the DNA sequencing industry are surge in clinical assessment through personalized genomics, increase in oncological research, demand for easy and fast clinical diagnosis, and adoption of high throughput technology.

Various factors leading to the growth of the DNA sequencing industry include the rise in technological advancements, increase in collaborations & partnerships of key players, and global increase in genome mapping programs. Additionally, rise in R&D investment also enhances the growth of the market and provides lucrative opportunities to the key players. Some of the challenges hindering the growth of the market are concerns related to the accuracy & standardization, along with the ethical & legal limitations posed with DNA sequencing.

Download report sample at: https://www.psmarketresearch.com/market-analysis/dna-sequencing-market/report-sample

The DNA sequencing industry provides immense opportunities for the new players to grow, due to the eminence of latest innovative technology in the market. Subsequently, the key players are also exploring opportunities by leveraging their precedence in technological advancement. The advent of next generation DNA sequencing (NGS) also provides opportunities for the market players to grow in the future.

Some of the key players in the global market include Illumina, Inc, Pacific Biosciences of California, Inc., Siemens AG, ZS Genetics, Inc, Abbott Laboratories, Li-Cor, Inc., F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies, and Agilent Technologies, Inc.

Read More

How is Unhealthy Lifestyle of People Driving Complementary and Alternative Medicines Market?

Due to globalization and urbanization, the lifestyle of people across the world has changed drastically. At the present time, a large number of people are suffering from medical conditions such as stress, obesity, hypertension, and insomnia. For instance, as per the Our World in Data, in 2017, 3.4% and 3.8% people across the globe were suffering from anxiety and depression, respectively. Apart from this, the prevalence of chronic diseases is on the rise as well; for example, the number of people suffering from diabetes grew from 108 million in 1980 to 422 million in 2014, according to the World Health Organization (WHO). The symptoms of these medical conditions can be managed by alternative therapies and medicines, including meditation, yoga, and tai chi, which is why the demand for complementary and alternative medicines (CAM) is rising.

The remedies or treatments that are used in place of conventional medical treatments, such as chemotherapy, surgery, allopathic medicines, and radiation therapy, are called CAM. Some examples of CAM are chiropractic, acupuncture, traditional medicine (herbal and ayurvedic), yoga, reiki, and homeopathy.

To Learn More About this Report at: http://bit.ly/35RBbg4

As per a research conducted by P&S Intelligence, in 2018, the global complementary and alternative medicines market reached a value of $192.0 billion and is predicted to register a 6.0% CAGR in the near future. The various types of CAM are mind-body intervention-based, nature-based, energy-based, and manipulative body-based. Among all these, the largest demand was created for nature-based CAM during 2014–2018. This was attributed to the increased requirement for organic and natural medications, which have less side-effects as compared to allopathic drugs. Ayurveda, mud therapy, and homeopathy are primary types of nature-based CAM.

One of the key reasons for the growing demand for CAM is the side-effects associated with allopathic medications. Several incidents of side-effects, such as diarrhea, vomiting, internal bleeding, dizziness, seizure, and insomnia, have been reported by patients taking allopathic medicines. For instance, aspirin, one of the most common drugs, is believed to cause side-effects including vomiting, heartburn, and seizures. These side-effects can happen because of various reasons, such as drug-food interaction and drug-drug interaction. Attributed to these factors, the consumers have started adopting alternative therapies and medicines, as they help in the management of several diseases without any major side-effects.

Read More

Cartilage Repair Market Trends, Business Strategies and Opportunities with Key Players Analysis 2024

The global cartilage repair market is witnessing considerable growth due to increasing geriatric population, increasing obesity, increasing healthcare expenditure, and growing sports related injuries. Moreover, increase in innovative product launches and growth of medical tourism leading to awareness about the cartilage treatment modalities across the globe is supporting the growth of the market. Based on the treatment modalities, cell-based approaches segment is expected to grow at the fastest rate during the forecast period, due to long term results of this treatment.

To Learn more About this Report: http://bit.ly/2mNYjKp

The rapid growth in emerging economies and technological advancement in cartilage repair and regeneration products is expected to create opportunities for the manufacturers of cartilage repair products across the globe. However, the high cost of these products and lack of reimbursement for these treatments are the key factors hampering the growth of the global market.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=cartilage-repair-market

Obesity is a serious health concern in the U.S. The increasing prevalence of obesity is driving the growth of the cartilage repair market in the U.S. According to CDC, during 2011-2012, 35.1% of adult aged 20 years or above were obese. In addition, as published by the Organization for Economic Cooperation and Development (OECD) in the year 2014, the obesity rate in Germany increased from 11.5% in 1999 to 14.7% in 2009. This increase in obesity rate leads to increase in demand for liposuction procedures, which is further accelerating the market growth.

The key players operating in the global cartilage repair market are Zimmer Biomet Holdings, Inc., Johnson & Johnson, Vericel Corporation, Smith & Nephew PLC, Osiris Therapeutics, Inc., RTI Surgical, Conmed Linvatec, B. Braun Melsungen AG, Anika Therapeutics S. R. L.  and Arthrex, Inc.

Read More

Anti-Microbial Coating for Medical Devices Market Share and Forecast Report 2024

The global anti-microbial coating for medical devices market is growing, due to increasing number of hospitals and surgical centers, increasing number of free trade agreements, and technological advancement, such as nanocomposite coating technology, novel coating technology and parylene technology. The metallic coating segment is expected to dominate the market and non-metallic segment is expected to grow at the faster rate during the forecasted period. The silver coating is expected to dominate the metallic coating segment of the global market, and anticipated to grow with the fastest rate during the projected period. In addition, the polymer coating segment is expected to dominate the non-metallic coating segment of the market. On the basis of device type, the catheter segment dominates the market; however, the implantable devices segment is expected to grow with the fastest rate during the forecast period.

The massive unexplored market of the anti-microbial coating for medical devices industry in the developing economies is creating abundant growth opportunities for the market. Various medical devices comes in contact with complex bodily fluids, such as blood and urine; these devices need to be sanitized with anti-microbial coating. Antimicrobial coating is used in medical devices to reduce the risk of infection and demolish microorganisms from medical devices. These coatings should be bio-compatible, bio-stable and non-toxic for various medical devices.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=anti-microbial-coating-for-medical-devices-market

Asia-Pacific is expected to be the fastest growing region in the market, due to increasing number of hospitals, improving healthcare infrastructure, and increasing geriatric population in the region. In addition, the Asia-Pacific market of anti-microbial coating for medical devices is growing, due to increasing demand for high quality medical devices, increasing geriatric population, and increasing number of endoscopic surgeries in the emerging countries, such as India and China.

Anti-Microbial Coating for Medical Devices Market Segmentation

By Type of Material

• Metallic Coating
  • Silver coating
  • Copper coating
  • Others metallic coating
• Non-metallic Coating
  • Organic coating
  • Polymeric coating

By Device Type

• Implantable Devices
• Surgical Instruments
• Catheters
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World

Read More

Medical Carts Market Research Report with Growth Analysis, Key Players and Forecast to 2024

The global medical carts market is projected to witness significant growth during the forecast period; owing to the increasing number of technological advancements, and rising focus on improving patient safety and nursing efficiency. In terms of product, the market is categorized into mobile computing carts, wall-mounted workstations, medication carts, and medical storage columns, cabinets, and accessories.

Medical carts can either be powered or manually operated, that is non-powered, based upon the requirements of the healthcare facilities. Non-powered carts are projected to generate higher revenue in the coming years, globally. In the medical carts market, StyleView laptop cart by Ergotron Inc., and Vintage Series treatment cart and Avalo emergency cart by Capsa Healthcare Inc. are some product examples of powered and non-powered medical carts, respectively.

To Learn More About this Report: http://bit.ly/2qoGdRU

North America is expected to be the largest contributor to the global medical carts market in the coming years, owing to the increasing patient base, increasing healthcare expenditure, and early adoption of latest technologies in the region. However, during the forecast period, the market in Asia-Pacific is expected to witness the highest growth and demand for these products. The major factors driving the market growth in the region are rapid economic growth, advancements in private and public hospitals, and rising healthcare reforms issued at various government levels including, state council and national health commission.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-carts-market

Growth in the medical carts industry is affected by various macro- and micro-economic factors, such as rising need for point-of-care facilities, surge in healthcare industry, and rising number of healthcare reforms. Manufacturers are focusing on developing carts that are equipped with the United States Food and Drug Administration (USFDA) approved battery systems, and advanced technological features, such as wireless technology, in order to support the increasing need to perform multiple tasks in the healthcare institutions.

Some of the key players in the medical carts industry are Medline Industries Inc., Capsa Healthcare, Scott-Clark Medical, Extron Inc., InterMetro Industries Corporation, Detecto Scale, Armstrong Medical Inc., Midmark Corporation, The Harloff Company, Novum Medical Products, AFC Industries, Ergotron Inc., and ITD GmbH.

Read More

Embolotherapy Market in North America is Expected to Hold Around 40% Share by 2024

The global embolotherapy market is projected to reach $4.8 billion by 2024, progressing at a CAGR of 8.0% during the forecast period.

Globally, the adoption of embolic procedures for the management of various diseases is increasing, owing to the rising healthcare spending and increasing patient pool. Furthermore, most of the patients who are diagnosed at intermediate stage and advanced stage, do not respond to curative therapies, such as ablation, surgical resection, and liver transplantation. Thus, increasing pool of patients, at an advanced stage of various life-threatening diseases, which require embolotherapy intervention, is a key driver supporting the growth of the embolotherapy market.

Globally, the North American embolotherapy market is expected to hold around 40% share by 2024. This can be mainly attributed to the rising cases of chronic diseases and increasing geriatric population.

Europe, APAC, LATAM, and Middle East and Africa are the other regions, which hold considerable shares in the embolotherapy market, on account of rising prevalence of cancer, and peripheral vascular and neurological diseases in these regions.

Manufacturers in the embolotherapy market are involved in product launches to increase their shares. For instance, in 2018, Medtronic Plc launched OptiSphere embolization spheres in the U.S., as well as Concerto 3D detachable coil system in Ireland.

Browse full report at: https://www.psmarketresearch.com/market-analysis/embolotherapy-market

Stryker Corporation, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Johnson and Johnson, Cook Medical Inc., Boston Scientific Corporation, BTG Plc, Balt Extrusion, and Acandis GmbH and Medtronic Plc are some of the major players operating in the global embolotherapy industry.

Read More

Global Clinical Laboratory Services Market Rising Growth and Future Analysis

The global clinical laboratory services market is growing significantly due to the advances in diagnostic techniques, increasing incidences of chronic diseases, and increasing geriatric population. Healthcare providers’ compliance for clinical diagnostic services is increasing due to the increasing demand for reducing hospitalization time and hospital readmission rates. This in turn propels the growth of the global clinical laboratory services market. Massive unexplored clinical laboratory services market in emerging economies is creating ample opportunities for the global clinical laboratory services market to grow at a considerable rate in the coming years. Several pharmaceutical companies investing huge capital for the development of advanced clinical laboratory devices is also supporting the demand for cost effective and efficient clinical laboratory services.

The global clinical laboratory services market is categorized as clinical laboratory service providers and clinical laboratory test types. Based on clinical laboratory service providers, the clinical laboratory services market is categorized as clinic-based laboratory service providers, stand-alone laboratory service providers, and hospital-based laboratory service providers. Based on clinical laboratory test types, the clinical laboratory services market is categorized as medical microbiology and cytology laboratory tests, clinical chemistry laboratory tests, human and tumor genetics tests, and other esoteric tests.

To Learn more about this report: http://bit.ly/2MGCoPb

Some of the factors driving the growth of the global clinical laboratory services market are advances in diagnostic techniques, increasing geriatric population, increasing healthcare providers’ compliance for diagnostic test and services, and increasing investment by big biopharmaceutical companies in the clinical laboratory services market. In addition, increasing prevalence of chronic diseases and increasing healthcare expenditure are supporting the growth of the global clinical laboratory services market. However, stringent regulatory requirements and lack of skilled professionals are some of the factors inhibiting the growth of the global clinical laboratory services market to some extent.

Some of the major players operating in the global clinical laboratory services market are ARUP Laboratories, Abbott Laboratories, Bio-Reference Laboratories, Charles River Laboratories, Bioscientia Healthcare, Genoptix Medical Laboratory, Healthscope Ltd, Laboratory Corporation Of America Holdings, Labco S.A., Quest Diagnostics Inc., Spectra Laboratories, Sonic Healthcare Limited, and Genoptix Medical Laboratory.

Read More

Medical Device Connectivity Market Predicts it to Witness Healthy Growth During the Forecast Period

The global medical device connectivity market is witnessing considerable growth due to increasing implementation of electronic health records and health information exchange systems, increasing regulations for improving healthcare quality, growing demand for home healthcare due to increasing geriatric population, improved diagnosis of patient, and increasing healthcare IT initiatives. Moreover, increasing prevalence of chronic diseases, increasing emphasis on care quality and patient safety, and increasing need to reduce healthcare costs through a connected healthcare environment are supporting the demand of medical device connectivity.

To Learn More About this Report: http://bit.ly/2MAUz99

The medical device connectivity aids in data analytics and growing adoption of telehealth solutions are also driving the growth of the market. Based on product type, the market for service segment is expected to grow at the faster rate compared to solution during the forecast period, due to increasing requirement for maximum consumption of connectivity solutions by the user, increasing regulatory requirements and healthcare reforms, increasing implementation of healthcare information exchange system, and increasing need for effective implementation.

Inquiry Before Purchase at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=medical-device-connectivity-market

The increasing demand for remote patient monitoring and telehealth, and increasing alliance in the healthcare industry are expected to create opportunities for the players in the market. In addition, immense unexplored market in developing economies are creating abundant opportunities for the medical device connectivity market to grow at a significant rate in the coming years. However, high cost of implementation for medical device connectivity platform in small healthcare organizations, lack of integration between various hospital information systems and medical devices, lack of standard interface, interoperability issues, security concerns, cost barrier for small healthcare units, and risk of data breaches are the key factors hampering the growth of the global market.

The key players operating in the global medical device connectivity market are GE Healthcare, Cerner Corporation, Cisco Systems Inc., Qualcomm Inc., Koninklijke Philips N.V., Medtronic Plc., Infosys Limited, and Digi International Inc.

Read More

Companion Diagnostics Market Rising Growth and Future Analysis

Companion diagnostics offers a set of tools that facilitates biological and clinical information to the pharmaceutical companies that they have to overcome. Companion diagnostics help physicians to improve the treatment decisions for the patients depending on their response to current treatments. Companion diagnostics approach to medication is transforming the healthcare industry by eliminating unfavorable reactions, improving treatment outcomes, and reducing the cost and time difficulties associated with conventional methods of medication. Companion diagnostic is basically a bio-analytical method designed to evaluate whether the patient will respond favorably to the specific medical treatment or not. The market is fully dependent on discovery of biomarkers, and research and development of new drugs. With the surge in research and development of targeted rehabilitations and innovation of new biomarkers for a range of conditions, the global companion diagnostics market is growing at healthy rate.

Increasing scope for companion diagnostics and emerging technologies, such as next-generation sequencing (NGS), are some of the major opportunities for the global companion diagnostics market. Some of the major factors driving the growth of global companion diagnostics market are growing adoption of companion diagnostics by pharmaceutical companies and reference laboratories, regulatory bodies encouraging implementation of companion diagnostics, increasing demand and developmental of personalized medicine and rising demand for targeted cancer treatment.

To Learn more About this Report: http://bit.ly/2MAOqcP

Reimbursement scenario, effect of influence of advocacy groups and clinical societies, and extended developmental and approval phases are some of the factors that are restraining the growth of global companion diagnostics market. One of the major challenges for the companion diagnostics market is co-ordination in the development of drugs and diagnostics together.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=companion-diagnostics-market

North America had the largest companion diagnostics market because of the increasing incidence of cancer and increased healthcare awareness. Whereas, Asia-Pacific is the fastest growing market of companion diagnostics owing to the strengthening healthcare services and increasing medical tourism in developing countries such as India and China.

Read More

Adhesion Barrier Market is Expected to Generate Revenue of $833.1 Million by 2023

Growth in geriatric population, coupled with the rising incidence of chronic diseases, is resulting in an increased number of surgeries across the world. Along with advancements in healthcare technology, these have become the major growth factors for the global adhesion barrier market. Valued at $541.3 million in 2017, the domain is expected to generate revenue of $833.1 million by 2023, progressing at a CAGR of 7.5% during forecast period.

Adhesion barrier is a physical barrier applied between the layers of tissue during surgery, so that operated-upon tissues do not overlap with other tissues and organs while healing. Once the surgical site heals, the barrier itself is dissolved and absorbed by the body. The adhesion barrier market has been segmented by product, formulation, application, and geography. Adhesion barriers are available in two product types: synthetic and natural. Of the two, synthetic adhesion barriers were preferable during the historical period 2013–2017, owing to their higher flexibility and bioabsorbility. In 2017, these made a revenue contribution of 67.2% to the market.

To Learn More About this Report: http://bit.ly/2oczdqr

According to a report published by the World Health Organization (WHO) in 2016, approximately 266–360 million surgeries were performed in 2012 globally. Due to the increasing incidents of chronic diseases, such as arthritis and cardiovascular diseases, which require surgical intervention as a therapeutic procedure, the demand for adhesion barriers has increased. This is expected to drive the growth of adhesion barrier market in the forecast period.

GLOBAL ADHESION BARRIER MARKET SEGMENTATION

By Type of Product

• Synthetic Adhesion Barrier
• Regenerated Cellulose
• Hyaluronic Acid
• Polyethylene Glycol
• Others
• Natural Adhesion Barrier
• Fibrin Based
• Collagen & Protein Based

By Product Form

• Film Formulation
• Gel Formulation
• Liquid Formulation

By Application

• Gynecological Surgeries
• Cardiovascular Surgeries
• Neurological Surgeries
• Orthopedic Surgeries
• General/Abdominal Surgeries
• Urological Surgeries
• Others

By Geography

• North America - U.S. and Rest of North America
• Europe - U.K., Germany, France and Rest of Europe
• Asia-Pacific - China, Japan, India and Rest of Asia-Pacific
• Latin America – Brazil, Mexico and Others
• Middle East and Africa

Read More

Ambulatory EHR Market Size, Key Players, Segments Analysis and Forecast to 2023

The growing use of electronic health records and need for reducing the overall healthcare cost are two of the key factors behind the prosperity of the ambulatory EHR market. In the year 2016, the market generated a revenue of $4.0 billion, and it is predicted to attain a value of $6.0 billion by 2023, progressing at a CAGR of 5.9% during the forecast period (2017–2023).

Ambulatory EHR is a record of a patient’s medical history, which is stored in an electronic database that is accessible by doctors and other medical professionals anytime from anywhere. Based on delivery mode, the ambulatory EHR market is bifurcated into cloud-based and on-premises solutions. Of these, during the historical period (2013–2016), the cloud-based solutions bifurcation led the market in terms of revenue, and it is predicted to continue leading it during the 2017–2023 period. This is attributed to the cost-effectiveness of cloud-based solutions as compared to on-premises solutions.

To Learn More About This Report: http://bit.ly/2CM7U8z

As per the data reported by the Office of the National Coordinator for Health IT, a company that implements the usage of electronic exchange of health data and upgraded health information technology, nearly 94.0% of regional extension centers (REC) registered as Priority Primary Care Providers (134,978 providers) had an EHR and were continuously deploying the technology. Further, more than 77.0% of the total REC-enrolled PPCPs (110,107 providers) had showed meaningful use of certified EHR technology (CEHRT) in e-prescribing, clinical quality reporting, and medical reconciliation.

The lack of communication between healthcare professionals and patients adversely impacts the cost and quality of healthcare, leading to the fragmentation of healthcare information, such as medical and diagnosis history, billing and administrative data, patient demographics, and medication schedule. The increasing demand for the availability of a patient’s entire healthcare data in one place is predicted to accelerate the adoption of advanced, integrated healthcare systems during the forecast period, which will continue to aid the ambulatory EHR market progress.

Hence, the reducing overall healthcare cost and rising deployment of EHR solutions are projected to boost the growth of the market.

Read More

Healthcare Insurance Market Overview, Share, Growth Drivers and Forecast to 2024

The global healthcare insurance market is projected to contribute a revenue of $2.2 trillion by 2024. Increasing prevalence of chronic diseases, rising geriatric population, growing GDP and healthcare expenditure, and high medical costs are driving the progress of the sector. Healthcare insurance is a kind of insurance that covers surgical and medical expenses, which is directly paid to healthcare providers for the treatment of an insured individual. The policy holder can pay the premium monthly or annually on their discretion.

Learn more about this report: http://bit.ly/2O9y8by

Based on coverage type, the healthcare insurance market is categorized into lifetime and term coverages. Out of these, in 2018, the term coverage category contributed a revenue of $1.3 trillion and is expected to be the faster-growing category, advancing at a CAGR of 4.7% in the analysis period. Term coverage is a fixed-term policy, which provides benefit upon the death of an insured individual. Due to the benefits associated with term coverage, such as low-cost premium and receipt of a lump sum amount when the term ends, the category is predicted to progress.

Now, when segmented by insurer type, minors, adults, and senior citizens are the divisions of the healthcare insurance market. Out of these, insurance plans for adults are anticipated to dominate the market across the globe. In 2018, adults generated a revenue of nearly $0.9 trillion for the market, which is projected to reach $1.2 trillion by 2024. On the other side, the minors category is expected to witness slower growth, advancing at a CAGR of 2.9% in coming years, owing to the fact that minors are dependent on adults and mostly covered in the insurance plans for grown-ups.  

Currently, the world is experiencing a significant rise in the geriatric population. In 2017, according to the World Population Prospects report published by the United Nations, geriatric population is predicted to grow faster as compared to the that of other age groups. The report states that there were 962 million people aged 60 years and above in 2017, globally, and this number is estimated to reach 1.4 billion by 2030, 2.1 billion by 2050, and 3.1 billion by 2100. This is further expected to result in the growth of the healthcare insurance market, as more aged people will lead to more plans being sold.

Hence, with the increase in the geriatric population across the globe, the demand for healthcare insurance plans is expected to rise.

Read More

E-Prescribing Market Outlook, Growth Prospects and Key Opportunities

E-Prescribing system facilities the practitioner to generate a new prescription electronically whenever treatment error occurs during healthcare operations. E-Prescribing system offers extensive range of applications. It provides comprehensive form of medical data, ensures all security checks and patents identification. It offers complete privacy to the disease information and patient’s identification with present and historical data.

Based on the different product type the global e-prescribing market can be broadly classified as, stand-alone systems, and integrated systems. Based on the different components of electronics prescribing the global e-prescribing market can be segmented as software and hardware (including access devices, peripherals, servers, storage devices, and networking devices) and services (including consulting, implementation services, post-sale & maintenance and training services). On the bases of mode of the delivery of the e-prescription the global e-prescription market can be classified as on premise, web-based and cloud. Further, based on the end user application the market can be segmented as hospitals and office-based physicians.

Europe was the largest market of e-prescription in 2013, followed by North America and Asia Pacific region. The market of e-prescription in Middle East, and Africa are in nascent stage. Asia Pacific and North America are two of the fastest growing market of the E-prescription. Country wise, U.S. is the largest market of e-prescription in North America. Germany, Italy, and Spain are some of the major market of e-prescription in Europe. In Asia Pacific, China, Japan, and India are fastest growing market of e-prescription attributed mainly to the strengthening healthcare services and advancement of the information technology in this region.

Major Competitors: The global e-prescription market is dominated by Bioclinica, Inc., Bizmatics Inc., CRF Health, DATARAK International, Inc., eResearch Technology, Inc., Some of the top competitors in the global clinical trial management system market are e-MDs, Inc., iMedX, Inc., Practice Fusion, Inc., SureScripts-RxHub, LLC, eClinicalWorks, LLC, and Quality System, Inc.

Read More

Technological Advancements Strengthening Cleanroom Technology Market

The favorable healthcare regulations, rapid developments in technology, and surging prevalence of infectious diseases are some of the key factors responsible for the growth of the cleanroom technology market. In 2016, the market attained a size of $3.4 billion, and it is expected to generate a revenue of $5.0 billion by 2023, progressing at a 5.7% CAGR during the forecast period (2017–2023). A cleanroom is an enclosed space, which is built to prevent harmful substances released by various airborne particles, including microorganisms, chemicals, and harmful radiations, such as ultraviolet rays, from polluting the space.

Based on end user, the cleanroom technology market is categorized into medical device, biotechnology industry, and pharmaceutical industry. Out of these, in 2016, the pharmaceutical industry held the largest revenue share of more than 40.0% in the market, and it is predicted to continue leading it during the 2017–2023 period. This is attributed to the expanding biopharmaceutical sector, which is accelerating the manufacturing of pharmaceutical products across the globe. As per the United States Food and Drug Administration, it is essential to implement specified guidelines for all food and pharmaceutical industries.

The global cleanroom technology market has been witnessing various technological developments, which are helping in improving the efficiency of cleanrooms with the high production of advanced sterile products. These upgraded products aid in providing a cleaner environment to manufacture products. Also, these developments help in minimizing the defects in cleanroom designs and workflow, which is further predicted to surge the demand for cleanrooms. Technological developments in equipment, such as heating, ventilation, and air conditioning systems and high-efficiency particulate air (HEPA) filters, offer better functionality of cleanrooms.

HEPA filters absorb nano-sized toxic compounds and improve the filtration process, which reduces the time taken for purifying the area. Additionally, the presence of modular cleanrooms, which are enclosed structures equipped with all devices, is expected to surge the production of cleanrooms, globally. In addition, customized cleanrooms are rapidly gaining popularity in the cleanroom technology market. Pressure, temperature, electrostatic charge, humidity, and magnetic flux can be modified as per customers’ need in a customized cleanroom. These cleanrooms are essential for research and development activities in the medical device, pharmaceutical, and biotechnology sectors.

Hence, the surging incidence of infectious diseases, technological advancements, and growing demand for customized cleanrooms are driving the growth of the market.

Read More

mHealth Market - Business Opportunities and Investment Research Report 2023

The global mHealth market is being driven by the increasing penetration of tablets and smartphones, and growing adoption of connected healthcare devices and mHealth apps. Rising geriatric population prone to chronic diseases, increasing focus on patent-centric healthcare, and growing demand for remote patient monitoring are also helping in this regard. Generating a revenue of $23.0 billion in 2017 as per a P&S Intelligence study, the market is predicted to advance through the forecast period 2018–2023 at a CAGR of 33.5%!

mHealth refers to the collection of medical data and delivery of healthcare services via mobile phones and tablets. On the basis of offering, the mHealth market can be divided into mHealth apps, connected devices, and services. Among these, the connected devices category led the market in 2017 with 57.2% share, due to a growing demand for remote patient monitoring solutions. In places, where people’s houses and healthcare centers are distant, these collect patients’ medical data and send it to medical practitioners via the internet, thus allowing for real-time disease management and improved patient outcomes.

Among the several types of connected devices available are blood pressure monitors, blood glucose monitors, multiparameter monitors, echocardiography (ECG) monitors, sleep apnea monitors, pulse oximeters, and others. In 2017, blood pressure monitors held the largest revenue share (28.7%) in the mHealth market owing to an increased prevalence of chronic disease and the easy mobility of such devices. While blood pressure monitors will still be the market leader during the forecast period, blood glucose monitors will witness the highest CAGR (31.9%) due to the increasing number of diabetes patients.

By recording and sharing medical data, connected devices and mHealth apps also lower the healthcare expenditure by minimizing hospital readmissions, clinic revisits, medical tests, and other physical examinations. A study, conducted by New York University, Harbin Institute of Technology and Carnegie Mellon University between 2015 and 2016, showed that mHealth helped reduce the glycated hemoglobin and blood glucose levels, hospital visits, and medical expenses of type 2 diabetes patients.

Therefore, it is clear that the growing prevalence of chronic diseases and the need to reduce healthcare costs will take the domain forward.

Read More

Top Key Players Operating In the Population Health Management Market and Growth Strategies

The population health management industry size is set to cross $48.1 billion by 2022. The growing geriatric population, increasing prevalence of chronic diseases, Affordable Care Act, increasing investments by HIT players and increasing healthcare spending are driving the growth of the PHM market.

The market for PHM in the European region is expected to cross $4.7 billion by 2022. The major factors driving the growth of the European population health management market include increase in demand for reducing healthcare cost, high prevalence of chronic diseases and increasing government initiatives. Aging population is another key factor driving the growth of the population health management industry in the region. The geriatric population is more susceptible to acquire diseases and hence, is at a higher risk of suffering from chronic diseases. Among the countries of the European region, Germany was the largest market for PHM, which is expected to grow at a CAGR of 22.8% during the forecast period to reach $1.5 billion by 2022.

Global Population Health Management Market Segmentation

By Delivery Mode

• Web based
• Cloud based
• On-premise

By Component

• Software
• Service

By End User

• Healthcare provider
• Healthcare payer
• Employer group
• Government bodies

By Geography

• North America
• U.S.
• Rest of North America
• Europe
• U.K.
• Germany
• Rest of Europe
• Asia
• Japan
• Rest of Asia
• Rest of the World (RoW)

Emerging economies offer huge market potential

Although, the population health management market is largely concentrated in the U.S., emerging economies such as China, India and Brazil offer ample growth opportunities. Huge unexplored market in the Asia and other developing regions create huge revenue generation opportunities for PHM vendors. The healthcare industry is witnessing significant growth in these countries. In addition, the large population base and improving healthcare infrastructure create suitable platform for the penetration of PHM in these countries.

Competitive Analysis

Cerner Corporation, McKesson Corporation, Allscripts Healthcare Solutions Inc., Wellcentive Inc., Conifer Health Solutions LLC., IBM Corporation, Optum, Inc., and Health Catalyst LLC are some of the key companies operating in the population health management market.

Read More